Saluda Medical, Inc. (ASX: SLD) - Share Price
Current share price for SLD : $0.225 0.005 (2.17%)+
Saluda Medical, Inc. (SLD) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a U.S.-based, commercial-stage medical device company initially founded in Australia. The Company is focused on developing treatments for chronic neurological conditions using our novel neuromodulation platform grounded in over 15 years of research and development.
SLD General Information +
| ASX Code | SLD |
| Website | N/A |
| Industry/Sector | Health Care Technology |
| Market Cap ($M) | 56 |
| SLD Share Price | $0.225 |
| Day High | $0.255 |
| Day Low | $0.225 |
| Last Close | $0.230 |
| SLD Share Price Movement | $0.01 ( 2.17% ) |
Prices as at 16:40, 6 Nov 2026
+Security prices are delayed by at least 20 minutes and are indicative only.
Saluda Medical, Inc. (SLD) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|
See all dividends from Saluda Medical, Inc. (SLD) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Saluda Medical, Inc. (SLD) price-sensitive announcements
SLD - Quarterly Investor Presentation
Saluda Medical’s FY27 Q1 Quarterly Investor Presentation highlights continued commercial m
Saluda Medical, Inc. (SLD)
29 Oct 2026 | 9:21 AM
29 Oct 2026 | 9:21 AM
SLD - Quarterly Activity Report
Saluda Medical’s Q1 FY27 Quarterly Activity Report for the quarter ended 30 September 2026
Saluda Medical, Inc. (SLD)
29 Oct 2026 | 9:20 AM
29 Oct 2026 | 9:20 AM
SLD - Quarterly Appendix 4C Cash Flow Report
Saluda Medical Inc.’s ASX Appendix 4C quarterly cash flow report for the quarter ended 30
Saluda Medical, Inc. (SLD)
29 Oct 2026 | 9:16 AM
29 Oct 2026 | 9:16 AM
SLD - CEO Transition
Saluda Medical, Inc. announced a CEO transition, with the Board appointing current Chief C
Saluda Medical, Inc. (SLD)
7 Sep 2026 | 11:43 AM
7 Sep 2026 | 11:43 AM
Saluda Medical, Inc. (SLD) Recent ASX Announcements
SLD Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2026A | -$217.74 | -$86.40 | -4.50% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2025A | -$227.94 | -$90.40 | 54.30% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2024A | -$147.69 | -$58.60 | 6.20% | 0.00 | 0.00 | 0.00% | 0.0% |
SLD Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | 2024 A | 2025 A | 2026 A | ||
| 4DMedical Limited (4DX) | $1,452M | 1.7823 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Artrya Limited (AYA) | $573M | -0.0450 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Pro Medicus Limited (PME) | $21,754M | 1.3034 | -0.2811 | 0.2395 | 82.1096 | 114.2175 | 92.1453 | 0.33% | 0.44% | 0.55% |
| Saluda Medical, Inc. (SLD) | $58M | -0.0447 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
SLD Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Mike Mathias | Chief Executive Officer, Executive Director | 24 Sep 2026 |
| Mr Douglas Evan Godshall | Non-Executive Chairman, Non-Executive Director | 15 Jun 2021 |
| Ms Catherine Brighid Livingstone | Non-Executive Director | 5 Feb 2013 |
| Dr Geoffrey Edward Duncan Brooke | Non-Executive Director | 20 Oct 2020 |
| Mr Robert Carrington Faulkner | Non-Executive Director | 28 Jun 2019 |
| Mr Robert Jon Palmisano | Non-Executive Director | 13 Apr 2022 |
| Mr Quentin Blackford | Non-Executive Director | 1 Dec 2025 |
Saluda Medical, Inc. (SLD) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|
See all changes in directors' interest & trades for Saluda Medical, Inc. (SLD) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
SLD Management
| Name | Position |
|---|---|
| James Erickson | Chief Financial Officer |
| Aidan OSullivan | Chief Operations Officer |
| David First | Chief People Officer |
| Dean Karantonis | Chief Technology Officer |
| Kristin Caplice | Company Secretary |
SLD Calendar of Events
| Date | Event |
|---|---|
| 22 October 2027 | Report (Annual) |
| 27 August 2027 | Report (Prelim) |
| 25 February 2027 | Report (Interim) |
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
